Lamellar vs creams in skincare formulation: engineered to behave like skin
Lamellar emulsions are built to mimic the skin’s own lipid matrix. Instead of random droplet dispersion, they form layered liquid-crystalline structures that align with the stratum corneum lipid bilayers. That matters more than it sounds.
Research indexed on PubMed highlights that biomimetic lipid systems can support improved stratum corneum organization and reduced transepidermal water loss (TEWL) compared to conventional emulsions, particularly in compromised or dry skin states.
Frontiers reviews in dermatological formulation science further point to lamellar systems as controlled-release vehicles, improving the residence time and bioavailability of active ingredients such as ceramides, niacinamide, and lipophilic antioxidants.
From a formulation standpoint, the advantage is structural stability under physiological conditions, less reliance on synthetic emulsifier loads, more compatibility with skin lipids, and a closer replication of natural barrier function.
Lamellar vs creams: barrier function differences
Conventional creams, typically oil-in-water or water-in-oil systems, rely on emulsifiers to hold phases together. They are efficient, scalable, and cost-effective, which explains their dominance in mass manufacturing.
But structurally, they are fundamentally different from skin.
They do not form lamellar lipid networks and therefore depend more heavily on occlusion and humectants for hydration performance. While they can deliver short-term moisturisation effectively, literature suggests they are less efficient in restoring lipid barrier architecture when compared to biomimetic systems.
This is where formulation intent becomes critical: hydration versus barrier repair are not the same outcome, even if they feel similar in consumer testing.
Why B2B formulators are shifting toward lamellar systems
The market signal is clear: clinical skincare, sensitive-skin categories, and dermatology-led brands are moving toward biomimetic delivery platforms. Key drivers include:
- Demand for microbiome-friendly, low-irritation systems
- Regulatory and clean-beauty pressure to reduce harsh surfactant loads
- Increased clinical validation requirements from retail buyers and dermatology channels
Industry literature consistently links lamellar structures with improved tolerability and enhanced active integration in the skin barrier matrix, especially in compromised skin models. In practical formulation terms, this changes everything, from emulsifier selection to preservative strategy and even manufacturing temperature thresholds.
What actually works?
If “works” means instant cosmetic feel, traditional creams still hold ground.
If “works” means barrier repair, lipid restoration, and performance under clinical scrutiny, lamellar emulsions are increasingly the superior system architecture.
Final word for formulators and brands
Brands that continue to build on legacy emulsification systems will remain competitive in appearance. Brands that transition into lamellar-based architectures will compete on physiology, not just perception.
If you’re developing next-generation skincare systems or rethinking your formulation platform, we can help you design for performance, not just texture. Contact HBM to explore lamellar and advanced formulation systems.
